VNRX · Categories · Form 4

VNRX - SEC Form 4 insider transactions

VolitionRX Limited (VNRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VNRX

• 83d
  SEC Form 4 filed by Rootsaert Rodney Gerard

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 83d
  SEC Form 4 filed by Forterre Gael

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 83d
  SEC Form 4 filed by Micallef Jacob Vincent

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 83d
  SEC Form 4 filed by Plummer Nicholas

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 99d
  GC - Volition Diagnostics Plummer Nicholas covered exercise/tax liability with 5,867 shares, decreasing direct ownership by 1% to 414,270 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 99d
  Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 3,321 shares, decreasing direct ownership by 1% to 277,941 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 99d
  Chief Commercial Officer Forterre Gael covered exercise/tax liability with 2,283 shares, decreasing direct ownership by 0.67% to 336,589 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Director Rubin Ethel was granted 178,000 shares, increasing direct ownership by 237% to 252,948 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Secretary Rootsaert Rodney Gerard was granted 119,000 shares, increasing direct ownership by 73% to 281,262 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  President and CEO Reynolds Cameron John was granted 486,000 shares, increasing direct ownership by 18% to 3,115,547 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Group Chief Marketing Officer Batchelor Ann-Louise was granted 142,000 shares, increasing direct ownership by 78% to 324,072 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Chief Commercial Officer Forterre Gael was granted 149,000 shares, increasing direct ownership by 78% to 338,872 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Chief Financial Officer Hughes Terig was granted 202,000 shares, increasing direct ownership by 42% to 684,970 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  GC - Volition Diagnostics Plummer Nicholas was granted 187,000 shares, increasing direct ownership by 80% to 420,137 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Director Nguyen Kim was granted 178,000 shares, increasing direct ownership by 139% to 305,816 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  CEO - Singapore Volition Kway Jasmine was granted 173,000 shares, increasing direct ownership by 70% to 418,614 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Chief Scientific Officer Micallef Jacob Vincent was granted 149,000 shares, increasing direct ownership by 35% to 577,489 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 103d
  Director Innes Guy Archibald was granted 178,000 shares, increasing direct ownership by 17% to 1,252,967 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 127d
  Chief Commercial Officer Forterre Gael covered exercise/tax liability with 2,010 shares, decreasing direct ownership by 1% to 189,872 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 127d
  Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 3,196 shares, decreasing direct ownership by 2% to 162,262 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 127d
  GC - Volition Diagnostics Plummer Nicholas covered exercise/tax liability with 5,647 shares, decreasing direct ownership by 2% to 233,137 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Rubin Ethel was granted 12,000 shares, increasing direct ownership by 19% to 74,948 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Innes Guy Archibald was granted 12,000 shares, increasing direct ownership by 1% to 1,074,967 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Chief Commercial Officer Forterre Gael was granted 38,100 shares, increasing direct ownership by 25% to 191,882 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  President and CEO Reynolds Cameron John was granted 74,700 shares, increasing direct ownership by 3% to 2,629,547 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Colman Alan was granted 12,000 shares, increasing direct ownership by 5% to 257,364 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Group Chief Marketing Officer Batchelor Ann-Louise was granted 33,900 shares, increasing direct ownership by 23% to 182,072 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Still Timothy I was granted 90,000 shares, increasing direct ownership by 6% to 1,625,458 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Chief Financial Officer Hughes Terig was granted 49,200 shares, increasing direct ownership by 11% to 482,970 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Barnes Phillip was granted 12,000 shares, increasing direct ownership by 22% to 67,368 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  CEO - Volition Veterinary Butera Salvatore Thomas was granted 53,400 shares, increasing direct ownership by 17% to 375,203 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Chief Scientific Officer Micallef Jacob Vincent was granted 35,400 shares, increasing direct ownership by 9% to 428,489 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Secretary Rootsaert Rodney Gerard was granted 28,200 shares, increasing direct ownership by 21% to 165,458 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  GC - Volition Diagnostics Plummer Nicholas was granted 44,700 shares, increasing direct ownership by 23% to 238,784 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Nguyen Kim was granted 12,000 shares, increasing direct ownership by 10% to 127,816 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  Director Henshall Mickie was granted 12,000 shares, increasing direct ownership by 37% to 44,206 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 138d
  CEO - Singapore Volition Kway Jasmine was granted 42,000 shares, increasing direct ownership by 21% to 245,614 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 218d
  Chief Medical Officer Retter Andrew covered exercise/tax liability with 4,588 shares, decreasing direct ownership by 3% to 146,568 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 218d
  GC - Volition Diagnostics Plummer Nicholas covered exercise/tax liability with 5,647 shares, decreasing direct ownership by 3% to 194,084 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 218d
  Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 3,197 shares, decreasing direct ownership by 2% to 137,258 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 218d
  CEO - Volition Veterinary Butera Salvatore Thomas covered exercise/tax liability with 4,648 shares, decreasing direct ownership by 1% to 321,803 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 218d
  Chief Commercial Officer Forterre Gael covered exercise/tax liability with 1,753 shares, decreasing direct ownership by 1% to 153,782 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 4,620 shares, decreasing direct ownership by 3% to 140,455 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  Chief Commercial Officer Forterre Gael covered exercise/tax liability with 5,389 shares, decreasing direct ownership by 3% to 155,535 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  CEO - Volition Veterinary Butera Salvatore Thomas covered exercise/tax liability with 5,834 shares, decreasing direct ownership by 2% to 326,451 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  Group Chief Marketing Officer Batchelor Ann-Louise covered exercise/tax liability with 6,110 shares, decreasing direct ownership by 4% to 148,172 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  Chief Operating Officer Michel Gaetan covered exercise/tax liability with 12,333 shares, decreasing direct ownership by 5% to 256,746 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  GC - Volition Diagnostics Plummer Nicholas covered exercise/tax liability with 8,146 shares, decreasing direct ownership by 4% to 199,731 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 246d
  Chief Scientific Officer Micallef Jacob Vincent covered exercise/tax liability with 5,850 shares, decreasing direct ownership by 1% to 393,089 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 253d
  CEO - Volition Veterinary Butera Salvatore Thomas covered exercise/tax liability with 5,230 shares, decreasing direct ownership by 2% to 332,285 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 253d
  Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 4,158 shares, decreasing direct ownership by 3% to 145,075 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 253d
  Chief Scientific Officer Micallef Jacob Vincent covered exercise/tax liability with 5,568 shares, decreasing direct ownership by 1% to 398,939 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 253d
  Group Chief Marketing Officer Batchelor Ann-Louise covered exercise/tax liability with 5,604 shares, decreasing direct ownership by 4% to 154,282 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 253d
  Chief Operating Officer Michel Gaetan covered exercise/tax liability with 11,362 shares, decreasing direct ownership by 3% to 369,079 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 253d
  Chief Commercial Officer Forterre Gael covered exercise/tax liability with 5,503 shares, decreasing direct ownership by 3% to 160,924 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 295d
  Chief Financial Officer Hughes Terig was granted 26,143 shares, increasing direct ownership by 5% to 533,770 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 295d
  Group Chief Marketing Officer Batchelor Ann-Louise was granted 27,400 shares, increasing direct ownership by 21% to 159,886 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 295d
  Secretary Rootsaert Rodney Gerard was granted 15,223 shares, increasing direct ownership by 11% to 149,233 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 295d
  CEO - Volition Veterinary Butera Salvatore Thomas was granted 33,991 shares, increasing direct ownership by 11% to 337,515 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)
• 295d
  GC - Volition Diagnostics Plummer Nicholas was granted 24,031 shares, increasing direct ownership by 13% to 207,877 units (SEC Form 4)

  4 - VOLITIONRX LTD (0000093314) (Issuer)

Other VNRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends